A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$59,40
0,00%
(0,00) 1 HR
15 Okt, 21.31.36 GMT-3 · BRL
search
Semua simbol
| Simbol | Harga | Perubahan | Persentase Perubahan |
|---|
insights_autoMembuat insight teratas untuk A1LN34...
Pembukaan
R$58,26
Tinggi
R$59,40
Rendah
R$58,26
Kapitalisasi pasar
31,32Â M
Volume rata-rata
440,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
R$132,40
Harga rendah dalam 52 minggu terakhir
R$50,25
Saham beredar
133,81Â jt
Jumlah karyawan
2Â rb
Pembukaan
R$58,26
Tinggi
R$59,40
Rendah
R$58,26
Kapitalisasi pasar
31,32Â M
Volume rata-rata
440,00
Volume
0,00
Harga tinggi dalam 52 minggu terakhir
R$132,40
Harga rendah dalam 52 minggu terakhir
R$50,25
Saham beredar
133,81Â jt
Jumlah karyawan
2Â rb
Artikel berita
Dari sumber web dan partner berita
ad-hoc-news.de
·
10 jam yang lalu
Citigroup cuts target to USD 320 for Alnylam Pharmaceuticals stock
Alnylam
·
17 jam yang lalu
Alnylam to Webcast Conference Call Discussing Third Quarter 2026 Financial Results
BioSpace
·
2 hari yang lalu
Alnylam bulls and bears fight it out after business-shaking guidance cut
The Globe and Mail
·
2 minggu yang lalu
18 of 21 Analysts Still Think Alnylam Stock Is a Buy. Here's Why They're Right.
Profil
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
Tentang Alnylam Pharmaceuticals Inc Bdr